PharmiWeb.com - Global Pharma News & Resources
24-Aug-2022

Luciferase Assays Market Production, Growth, Share, Demand and Applications Forecast to 2032

The global luciferase assays market is estimated to be valued around US$ 1.3 Billion in 2022, and is likely to surpass US$ 3 Billion by 2032. A bioluminescence experiment requires a paired set of biochemical: an enzyme named luciferase and a substrate, which is a molecule that emits light upon interacting with the enzyme or photoprotein. For each of the bioluminescent system required there is a unique co- factors and buffers that are required. Around us there are a lot of biological, natural and light producing systems which produces the enzyme named luciferases.

The substrate of luciferases is coin as luciferins. Emil Heinrich DuBois-Reymond, a German physiologist coined both these terms. Luciferases and luciferins are both involved in totally different reactions. For instance, the most commonly used luciferase detects the biological energy molecule adenosine triphosphate.

Luciferase Assays Market: Drivers and Restraints 

The market for luciferase assay is expected to upsurge owing to its penetrating usage in research to study the gene expression. Moreover, these luciferases has become powerful tool in molecular biology and genetic engineering where they have replaced chloramphenicol acetyltrans-ferase gene as a reporter. Bioluminescence is now filling its own niches as well as competing with chemiluminescence.

ATP detection via firefly luciferase, for example, has no chemiluminescent counterpart. There is tremendous technological development in the luciferase assay market where the current luciferase technologies permit the quantitative visualization of gene expression at single-cell resolution by imaging its luminescence in real-time using a highly sensitive charged-coupled device (CCD) camera.

Luciferase Assays Market: Segmentation 

On the basis of assay type the luciferase assays market can be segment as: 

  • Beta-galactosidase (LacZ) assays
  • Luciferase assays
  • Fluorescent protein related assays
  • Chloramphenicol acetyltransferase (CAT) assays
  • Others

On the basis of application the luciferase assays market can be segment as: 

  • Gene expression
  • Post-translational modification
  • Protein-protein interaction
  • Metabolic activity
  • Others

Request Sample Report:

https://www.futuremarketinsights.com/reports/sample/rep-gb-5565

Luciferase Assays Market: Overview 

These luciferases are used in bioluminescence assays as researchers believe that where there is light there would be ATP and measuring the light emitted while carrying out the bioluminescence assay is the measure of the metabolic activity. Today luciferases is used in all forms of testing to check the ATP. It is used to check the microbial contamination in many of the beverages company.

There are a number of studies going on where the researchers link the interest gene with the luciferases to study the metabolic activity. The investigator through this linkage is able to follow gene expression at different stages of development in a transgenic organism.

In terms of geography, luciferase assays market has been divided into seven regions including North- America, Eastern Europe, Western Europe, Asia- Pacific excluding Japan, Japan Middle-East & Africa and Latin America. North America is expected to remain the dominating region while Asia Pacific is expected to emerge as a fastest growing region.

Strong research funding and government to study newer assay methods makes North America the dominating region. Economically developing regions such as Asia Pacific has many companies focusing their resources in this region and trying to explore the luciferase assay market potential.

Luciferase Assays Market: Key Market Participants 

Some of the luciferase assays market participants are Life Technologies, Sigma Aldrich, Thermo Fisher, Promega, Clontech, Invivogen, Roche Applied Sciences, Switchgear Genomics, Origene, Perkin Elmer, EMD Millipore, Clontech, Gold Biotechnology, Lonza and GE Healthcare Life Sciences.

New product launch, collaborations and acquisitions are few of the strategies the luciferase assays market players undertake. For instance, Promega Corporation introduced a new product named Nano-Glo Dual-Luciferase Reporter (NanoDLR) Assay, a two-reporter system that incorporates NanoLuc luciferase technology, providing increased data quality and greater sensitivity for biologically complex applications.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application, and industry.

The report covers exhaust analysis on 

  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

Regional analysis includes 

  • North America (U.S., Canada)
  • Latin America (Mexico. Brazil)
  • Western Europe (Germany, Italy, France, U.K, Spain)
  • Eastern Europe (Poland, Russia)
  • Asia Pacific (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC Countries, S. Africa, Northern Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-5565

Table of Content

  1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

  1. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

  1. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Investment Feasibility Matrix

3.6. PESTLE and Porter’s Analysis

3.7. Regulatory Landscape

3.7.1. By Key Regions

3.7.2. By Key Countries

3.8. Regional Parent Market Outlook

  1. Global Luciferase Assays Market Analysis 2017-2021 and Forecast, 2022-2032

4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

Inquire Before Buying This Research Report:

https://www.futuremarketinsights.com/ask-question/rep-gb-5565

About Us    

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs

Editor Details

Last Updated: 24-Aug-2022